Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin
Tóm tắt
Because interactions between cisplatin and plasma proteins contribute to drug efficacy and side effects, it is important to understand both the binding sites of cisplatin on the proteins and the formation of protein–cisplatin adducts. Previous results suggest that cisplatin preferentially binds to residues on the protein surface. The present work employed electrospray ionization mass spectrometry (MS) to identify such sites on both native and denatured ubiquitin (Ub). Fourier transform (FT) MS and tandem MS (MS/MS and MS3) enable analysis of Ub–cisplatin adduct digests to locate specific cisplatin binding sites. Results indicate that there are three such binding sites, i.e., M1, T12 and T14, and D32, on native Ub. The intensity of the relevant peaks in the FT-MS spectrum of the native Ub adduct digest demonstrates that residues T12 and T14 comprise the primary cisplatin binding site under the native conditions rather than residue M1 as reported in previous research studies. It is found in the present work, however, that M1 is the primary binding site on denatured Ub. Comparison of cisplatin binding sites on native and denatured Ub in this research demonstrates that the conformation of a protein significantly influences the preference of cisplatin for specific binding sites.
Tài liệu tham khảo
Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467–2498
Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320
Reedijk J (1999) Chem Rev 99:2499–2510
Appleton TG (1997) Coord Chem Rev 166:313–359
Allardyce CS, Dyson PJ, Coffey J, Johnson N (2002) Rapid Commun Mass Spectrom 16:933–935
Khalaila I, Allardyce CS, Verma CS, Dyson PJ (2005) ChemBioChem 6:1788–1795
Hartinger CG, Tsybin YO, Fuchser J, Dyson PJ (2008) Inorg Chem 47:17–19
Will J, Sheldrick WS, Wolters D (2008) J Biol Inorg Chem 13:421–434
Casini A, Gabbiani C, Michelucci E, Pieraccini G, Moneti G, Dyson P, Messori L (2009) J Biol Inorg Chem 14:761–770
Zhao T, King FL (2009) J Am Soc Mass Spectrom 20:1141–1147
Moreno-Gordaliza E, Cañas B, Palacios MA, Gómez-Gómez MM (2009) Anal Chem 81:3507–3516
Zhao T, King FL (2010) J Inorg Biochem 104:186–192
Vijay-Kumar S, Bugg CE, Cook WJ (1987) J Mol Biol 194:531–544
Peleg-Shulman T, Gibson D (2001) J Am Chem Soc 123:3171–3172
Peleg-Shulman T, Najajreh Y, Gibson D (2002) J Inorg Biochem 91:306–311
Williams JP, Phillips HIA, Campuzano I, Sadler PJ (2010) J Am Soc Mass Spectrom 21:1097–1106
Hartinger CG, Ang WH, Casini A, Messori L, Keppler BK, Dyson PJ (2007) J Anal Atom Spectrom 22:960–967
Gibson D, Costello CE (1999) Eur J Mass Spectrom 5:501–510
Kodali Ravindra Babu AM, Douglas DJ (2001) J Am Soc Mass Spectrom 12:317–328
Tang L, Kebarle P (1993) Anal Chem 65:3654–3668
Zhang Z, Marshall AG (1998) J Am Soc Mass Spectrom 9:225–233
Medzihradszky KF (2005) Methods Enzymol 402:209–244
Paizs B, Suhai S (2005) Mass Spectrom Rev 24:508–548
Will J, Wolters DA, Sheldrick WS (2008) ChemMedChem 3:1696–1707